Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection [Thoracic Oncology]

Conclusion The new lung adenocarcinoma classification based on predominant histologic pattern was not predictive for ACT benefit for OS, but it seems predictive for disease-specific outcomes.

http://jco.ascopubs.org/cgi/content/short/33/30/3439?rss=1

Source: Journal of Clinical Oncology - October 16, 2015 Category: Cancer & Oncology Authors: Tsao, Marguet, Le Teuff, Lantuejoul, Shepherd, Seymour, Kratzke, Graziano, Popper, Rosell, Douillard, Le-Chevalier, Pignon, Soria, Brambilla Tags: Diagnosis & Staging, Surgery, Chemotherapy, Pathology Thoracic Oncology Source Type: research